The FLT4 gene gives instructions for a protein that helps form and maintain lymphatic vessels, the channels that return extra fluid from tissues back into the bloodstream. This gene plays an important role in keeping fluid moving properly through the body. If the FLT4 gene does not work well, lymph fluid can build up and cause long-lasting swelling, often in the feet or legs from birth or early childhood, a condition called primary lymphedema. Some variants in this gene can also affect how the lymph vessel system develops more broadly.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate activities in the body. Some genes hold the information needed to produce proteins, which are the functional parts of cells. Other genes mostly guide when, where, and how much certain activities occur. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, and medications. If you want to look into this subject more closely, you can find more in the LearnHub.
Overview
FLT4Gene function
What if the gene works
The FLT4 gene helps build and maintain lymph vessels, which move fluid back into the bloodstream and support immune function. Early in development, it also helps guide blood vessel growth.
Risk
What if the gene does not work
Variants in the FLT4 gene impair lymph vessel development, causing lymphedema, leg swelling from birth or childhood. Effects range from milder to more severe, influencing when swelling begins and how marked it is; some variants are linked to heart conditions.
Treatment
What does that mean for your treatment
For pathogenic or loss-of-function variants in the FLT4 gene, no FLT4-specific treatment or drug choice is currently established in clinical guidelines. Care is based on standard lymphedema management rather than a medicine aimed at FLT4, while the VEGF-C/FLT4 signaling pathway is being studied as a possible treatment target in lymphedema and some cancers.
Conditions associated with FLT4
Gene function
What if the gene works
Your body needs a healthy lymphatic system to move extra fluid out of tissues and support immune traffic. The FLT4 gene helps build and maintain the vessels that do this work. Its protein sits on the surface of certain vessel lining cells and passes along growth signals. Understanding what the FLT4 gene does in the lymphatic system helps explain how tissues stay balanced day to day.
The FLT4 gene helps lymphatic vessels form, grow, and branch in an organized way. This gives the body a network of channels that can collect fluid from tissues and return it to the bloodstream.
Its protein acts like an antenna on lymph vessel cells, picking up growth messages from nearby tissues. These messages help cells know when to grow, move, and connect with each other.
The FLT4 gene supports the steady maintenance of mature lymphatic vessels over time. This helps the lymphatic system keep fluid moving and supports normal immune cell travel through the body.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help explain normal variation among people, such as appearance, metabolism, or the way the body reacts to environmental factors. Many variants do not have any noticeable effect and are simply part of natural genetic diversity. In some situations, though, a variant changes how a gene works more substantially and can contribute to, or directly cause, a genetic condition.
Genetic variants
What if the gene does not work
Variants in the FLT4 gene can make the protein less stable, reduce its activity, or stop it from sending normal cell growth signals. In some people, how FLT4 gene variants affect protein signaling depends on the change itself: milder variants may leave some function intact, while more severe variants can sharply reduce or abolish signaling. Changes that disrupt key signaling regions often have the strongest effect and may be linked to earlier onset or more marked lymphedema.
How variants are linked to conditions
Pathogenic variants in the FLT4 gene cause Milroy disease, an inherited form of primary lymphedema that often begins at birth or in early infancy, usually with lasting swelling of the feet and legs. Some people with FLT4-related lymphedema also have upturned toenails or a hydrocele, which is fluid around the testicle. Separate FLT4 variants have also been linked to a higher chance of certain congenital heart conditions, especially tetralogy of Fallot, although these associations do not guarantee that heart disease will occur.
A variant is not necessarily a diagnosis
Genetic variants are a common and normal feature of human biology across the general population. Most do not directly affect health and simply reflect natural differences among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences also play a role. In other situations, though, one well-understood variant in a particular gene is enough to confirm the diagnosis.
Are there things that can increase or change my risk?
For FLT4, the main driver of risk is whether you carry a disease-causing gene change, often inherited in a family. There is not broadly confirmed evidence that lifestyle factors change that inherited risk itself. In people living with FLT4-related swelling, infections, injury, extra body weight, and pregnancy can make symptoms more noticeable or harder to manage.
Inheritance of FLT4 variants
For families trying to understand how variants of the FLT4 gene are inherited, the best established pattern is autosomal dominant. This means a parent carrying a disease causing FLT4 variant can pass it to a child with a 50% chance in each pregnancy, regardless of the child's sex. Some people with an FLT4 related condition have a new, de novo variant that was not inherited from either parent. An affected person can pass the variant on to sons or daughters.
What does my FLT4 result mean for my family?
For FLT4, a disease-causing result is most often linked to an inherited pattern where close relatives can also carry the same change. This means parents, brothers, sisters, and children may also want to learn whether they have it, especially if there is leg or foot swelling in the family. Each child of someone with a disease-causing FLT4 change has a 1 in 2, or 50%, chance of inheriting it.
Genetic information
Genetic testing
How you find out about variants
FLT4 genetic testing uses a blood or saliva sample to examine the FLT4 gene and look for variants linked to inherited lymphedema. It can show whether you carry a known family variant or another relevant change, although the result still needs expert interpretation because some variants do not clearly affect health.
When should I consider getting a genetic test?
Consider testing for FLT4 if there is lifelong or early-onset swelling of the feet or legs from lymph fluid, especially if it runs in the family. A harmful FLT4 variant can confirm a diagnosis of Milroy disease and help clarify who else in the family may also be affected.
A genetic result is only one part of your health story
Genetic findings can provide useful insight, but how much they reveal depends on the condition and on the kind of variant involved. Over time, the way the body functions is shaped by many other influences, including lifestyle, environment, age, and medical history. In some conditions, especially those affected by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic finding may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target. As a result, the same treatment may work better for some people, have less effect in others, or make some people more sensitive to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medications. It focuses on links between genes and drugs to help explain why the same treatment may affect people in different ways. For many medicines, genes influence both how the body processes a drug and how strongly it works. This information can support more informed, individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the FLT4 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so general questions about medicines or side effects are best discussed with your doctor. Researchers have studied FLT4 in cancer treatment, especially with medicines that target blood vessel growth, but this has not become routine guidance for everyday care.
History
The FLT4 gene entered medical research in the 1990s, when scientists identified it as a member of a family of genes involved in blood and lymph vessel biology. Early studies first called its protein VEGFR3, a name still widely used in research. From these first observations, research expanded steadily, linking the FLT4 gene to the development of the lymphatic system, the network that helps move fluid through the body. A major milestone came when inherited variants in the FLT4 gene were found in some families with Milroy disease, a form of long standing swelling that often affects the legs from birth or early life. That discovery helped connect gene findings with a condition doctors could recognize in everyday care.